Article Text

Download PDFPDF
Different uses of the breast implant to prevent empty pelvic complications following pelvic exenteration
  1. Nail Omarov1,
  2. Derya Salim Uymaz1 and
  3. Dursun Bugra2
  1. 1General Surgery, Koç University Hospital, Istanbul, Turkey
  2. 2School of Medicine, Koç University, Istanbul, Turkey
  1. Correspondence to Dr Nail Omarov; dr_nail{at}


Pelvic exenteration surgery is used as a standard procedure in recurrent pelvic cancers. Total pelvic exenteration (TPE) includes resection of the uterus, prostate, ureters, bladder and rectosigmoid colon from pelvic space. Empty pelvis syndrome is a complication of the TPE procedure. Following TPE, complications such as haematoma, abscess leading to permanent pus discharge and chronic infections can occur. Herein, we present the case of a man in his 50s who was referred for pelvic pain, foul-smelling discharge and non-functioning colostomy, and operated for distal rectal cancer 1.5 years ago and underwent low anterior resection. In this case, we performed TPE for the recurrent tumour. To prevent TPE complications, we used a breast implant for filling the pelvic cavity. The early and late postoperative course was uneventful.

  • Surgical oncology
  • General surgery
  • Breast surgery
  • Plastic and reconstructive surgery
  • Gynecological cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors NO—methodology, project administration and writing (original draft). DSU—formal analysis and investigation. DB—supervision and validation.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.